Skip to main content
NIH funding notice PAS-10-273

Clinically Relevant Comparative Effectiveness of Alcoholism Treatments (R01)

Closed on September 7, 2013.

Posted
August 25, 2010
Close date
September 7, 2013
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $713,958 in first-year total cost, median $713,958.

Most frequent study sections

  1. Special Emphasis Panel[ZAA1 DD (03)]1

Most frequent institutions

  1. BOSTON UNIVERSITY MEDICAL CAMPUS1
Competing awards under PAS-10-273 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2014Oral v Injection Naltrexone in Hospital: Comparative Effectiveness for Alcoholism1R01AA021335-01A1SAITZ, RICHARDBOSTON UNIVERSITY MEDICAL CAMPUS, MA$713,958ZAA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.